Cargando…
1614. Single-Dose Doxycycline as Lyme Disease Post-Exposure Prophylaxis in a National Commercial Insurance Claims Database―the United States, 2014–2017
BACKGROUND: Approximately 300,000 cases of Lyme disease occur annually in the UNITED STATES, with children aged 5–9 years disproportionately affected. A single dose of doxycycline administered within 72 hours of a high-risk tick bite is recommended for post-exposure prophylaxis (PEP) to prevent Lyme...
Autores principales: | Marx, Grace E, Schwartz, Amy M, On, Camay, Hinckley, Alison F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6808904/ http://dx.doi.org/10.1093/ofid/ofz360.1478 |
Ejemplares similares
-
1428. Lyme Disease Treatment in the United States: Prescribing Patterns from a Nationwide Commercial Insurance Database, 2016-2018
por: Beeson, Amy M, et al.
Publicado: (2020) -
1198. Lyme Disease Post-Exposure Prophylaxis by Single-Dose Doxycycline in Three Healthcare Systems
por: Marx, Grace E, et al.
Publicado: (2021) -
Use of Commercial Claims Data for Evaluating Trends in Lyme Disease Diagnoses, United States, 2010–2018
por: Schwartz, Amy M., et al.
Publicado: (2021) -
153. Utilization of Post-Exposure Prophylaxis to Prevent Lyme Disease in a Large US Healthcare Database
por: Marx, Grace E, et al.
Publicado: (2021) -
Malaria Prophylaxis Failure with Doxycycline, Central African Republic, 2014
por: Madamet, Marylin, et al.
Publicado: (2015)